Reversion of patients with chronic migraine to an episodic migraine classification with fremanezumab treatment (vol 19, P7, 2018)

被引：0
|
作者：
Cohen, Joshua M. [1 ]
Bibeau, Kristen [1 ]
Galic, Maja [2 ]
Seminerio, Michael J. [1 ]
Ramirez Campos, Verena [3 ]
Singh, Rashmi B. Halker [4 ]
Ailani, Jessica [5 ]
机构：
[1] Teva Pharmaceut, Frazer, PA 19355 USA
[2] Teva Pharmaceut, Amsterdam, Netherlands
[3] Teva Pharmaceut, Buenos Aires, DF, Argentina
[4] Mayo Clin, Phoenix, AZ USA
[5] Medstar Georgetown Univ Hosp, Washington, DC USA
来源：
JOURNAL OF HEADACHE AND PAIN | 2018年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Reversion of Patients with Chronic Migraine to an Episodic Migraine Classification with Fremanezumab Treatment
    Singh, Halker R. B.
    Cohen, J. M.
    Bibeau, K.
    Galic, M.
    Seminerio, M. J.
    Campos, Ramirez, V
    Ailani, J.
    HEADACHE, 2018, 58 : 70 - 71
  • [2] Reversion of Patients With Chronic Migraine to an Episodic Migraine Classification With Fremanezumab Treatment
    Cohen, Joshua M.
    Bibeau, Kristen
    Galic, Maja
    Seminerio, Michael J.
    Campos, Verena Ramirez
    Singh, Rashmi B. Halker
    Ailani, Jessica
    NEUROLOGY, 2018, 90
  • [3] Reversion of Patients with Chronic Migraine to an Episodic Migraine Classification with Fremanezumab Treatment
    Cohen, Joshua M.
    Bibeau, Kristen
    Galic, Maja
    Seminerio, Michael J.
    Ramirez-Campos, Verena
    Singh, Rashmi B. Halker
    Ailani, Jessica
    ANNALS OF NEUROLOGY, 2018, 84 : S183 - S184
  • [4] Reversion of patients with chronic migraine to an episodic migraine classification with fremanezumab treatment
    Cohen, Joshua M.
    Bibeau, Kristen
    Galic, Maja
    Seminerio, Michael J.
    Ramirez Campos, Verena
    Singh, Rashmi B. Halker
    Ailani, Jessica
    JOURNAL OF HEADACHE AND PAIN, 2018, 19
  • [5] The impact of fremanezumab on symptoms associated with migraine in patients with episodic migraine (vol 19, pg P3, 2018)
    Brandes, Jan L.
    Yeung, Paul P.
    Aycardi, Ernesto
    Yang, Ronghua
    Ma, Yuju
    Cohen, Joshua M.
    JOURNAL OF HEADACHE AND PAIN, 2018, 19
  • [6] The impact of fremanezumab on symptoms associated with migraine in patients with chronic migraine (vol 19, P4, 2018)
    McAllister, Peter
    Yeung, Paul P.
    Aycardi, Ernesto
    Yang, Ronghua
    Ma, Yuju
    Cohen, Joshua M.
    JOURNAL OF HEADACHE AND PAIN, 2018, 19
  • [7] Achievement of response over time with fremanezumab in the treatment of chronic and episodic migraine (vol 19, pg P11, 2018)
    Silberstein, Stephen D.
    Lipton, Richard B.
    Diamond, Merle L.
    Cohen, Joshua M.
    Yang, Ronghua
    Jiang, Bo
    JOURNAL OF HEADACHE AND PAIN, 2018, 19
  • [8] Fremanezumab as a preventive treatment for episodic and chronic migraine
    Bigal, Marcelo E.
    Walter, Sarah
    Rapoport, Alan M.
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2019, 19 (08) : 719 - 728
  • [9] Efficacy and tolerability of fremanezumab for migraine preventive treatment in Korean patients with chronic or episodic migraine
    Kim, Byung-Kun
    Cohen, Joshua
    Kim, Sukyung
    Chang, Daeho
    Ning, Xiaoping
    Lengil, Tamar
    Janka, Lindsay
    Barash, Steve
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429 : 214 - 214
  • [10] Reductions in Migraine Frequency With Fremanezumab Treatment in Individuals With Chronic and Episodic Migraine
    Nahas, S. J.
    Ning, X.
    Cohen, J. M.
    Barash, S.
    Campos, V. Ramirez
    Silberstein, S. D.
    JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 1): : 114 - 114
12345